Cedar Brook Financial Partners, LLC Inovio Pharmaceuticals, Inc. Transaction History

Cedar Brook Financial Partners, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 05, 2023	BUY	$0.39 - $0.94 $9,999 - $24,102	25,641 Added 24.45%	130,522 $58,000
Q1 2023 Apr 04, 2023	BUY	$0.79 - $1.91 $12,743 - $30,810	16,131 Added 18.18%	104,881 $86,000
Q1 2022 Apr 06, 2022	BUY	$2.97 - $5.2 $101,722 - $178,100	34,250 Added 62.84%	88,750 $319,000
Q4 2020 Feb 12, 2021	SELL	$8.5 - $12.85 $3,400 - $5,140	-400 Reduced 0.73%	54,500 $482,000
Q2 2020 Aug 05, 2020	BUY	$7.14 - $31.69 $2,856 - $12,676	400 Added 0.73%	54,900 $1.48 Million
Q1 2020 May 07, 2020	BUY	$2.98 - $14.09 $38,740 - $183,170	13,000 Added 31.33%	54,500 $405,000
Q4 2018 Feb 11, 2019	BUY	$3.89 - $6.11 $161,435 - $253,565	41,500 New	41,500 $166,000

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $1.41B
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of Cedar Brook Financial Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Cedar Brook Financial Partners, LLC with notifications on news.